BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20003868)

  • 61. Ranolazine as add-on therapy for patients with severe chronic angina.
    Hooper JS; Busti AJ
    JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113810
    [No Abstract]   [Full Text] [Related]  

  • 62. Novel drugs for treating angina.
    Jones DA; Timmis A; Wragg A
    BMJ; 2013 Sep; 347():f4726. PubMed ID: 24018101
    [No Abstract]   [Full Text] [Related]  

  • 63. Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectoris.
    Rich MW; Crager M; McKay CR
    Am J Geriatr Cardiol; 2007; 16(4):216-21. PubMed ID: 17617747
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New angina medication approved.
    Health News; 2006 Jun; 12(6):2. PubMed ID: 16832877
    [No Abstract]   [Full Text] [Related]  

  • 65. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.
    Hidalgo-Vega A; Ramos-Goñi JM; Villoro R
    Eur J Health Econ; 2014 Dec; 15(9):917-25. PubMed ID: 24122303
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ranolazine: effects on ischemic heart.
    Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS
    Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ranolazine: a potential new treatment for chronic stable angina.
    Anderson JR; Khou S; Nawarskas JJ
    Heart Dis; 2001; 3(4):263-9. PubMed ID: 11975803
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ranolazine-induced severe bladder hypotonia.
    Panfili M; Iafrate M; Marzot F; Secco S; De Rosa G; Groppa F; Padrini R
    Ann Pharmacother; 2012 Sep; 46(9):e24. PubMed ID: 22828972
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.
    Pepine CJ; Wolff AA
    Am J Cardiol; 1999 Jul; 84(1):46-50. PubMed ID: 10404850
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ranolazine in patients with coronary artery disease.
    Scirica BM
    Expert Opin Pharmacother; 2007 Sep; 8(13):2149-57. PubMed ID: 17714067
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ranolazine-related dyspnea on exertion.
    Goswami R; Van De Car D; Schmader KE; Bashore TM; Sketch MH
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):73-6. PubMed ID: 20226394
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders.
    Bhandari B; Subramanian L
    Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):35-9. PubMed ID: 18221101
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rhabdomyolysis in a patient receiving ranolazine and simvastatin.
    Hylton AC; Ezekiel TO
    Am J Health Syst Pharm; 2010 Nov; 67(21):1829-31. PubMed ID: 20966146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of ranolazine in patients with stable angina pectoris.
    Khera S; Kolte D; Aronow WS
    Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ranolazine, a novel agent for chronic stable angina.
    Gaffney SM
    Pharmacotherapy; 2006 Jan; 26(1):135-42. PubMed ID: 16506355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanism of action of ranolazine.
    Marx C; Sweeney M
    Arch Intern Med; 2006 Jun; 166(12):1325-6; author reply 1326. PubMed ID: 16801521
    [No Abstract]   [Full Text] [Related]  

  • 78. Ranolazine: a new approach to treating an old problem.
    Reddy BM; Weintraub HS; Schwartzbard AZ
    Tex Heart Inst J; 2010; 37(6):641-7. PubMed ID: 21224931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myocardial metabolism: a new target for the treatment of heart disease?
    Taegtmeyer H; Salazar R
    Curr Hypertens Rep; 2004 Dec; 6(6):414-5. PubMed ID: 15527683
    [No Abstract]   [Full Text] [Related]  

  • 80. FDA okays new drug for tough-to-treat chest pain.
    Harv Heart Lett; 2006 Apr; 16(8):7. PubMed ID: 19685562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.